2020 Annual Meeting | IS1 - Invited Science: Child Neurology
| 03:30 PM - 03:50 PM | Speaker |
Gene Therapy for AADC deficiency: MRI-Guided Delivery of AAV2-hAADC to the Midbrain
Toni Pearson, MBBS |
| 03:50 PM - 04:10 PM | Speaker |
Exome sequencing in patients with cerebral palsy identifies an etiology in one-third of cases, underscoring the need for broad genetic testing and a significant recurrence risk for families
Francisca Millan Zamora, MD |
| 04:10 PM - 04:30 PM | Speaker |
Effect of Anti-Epileptic Drug Prophylaxis on Time to First Seizure Diagnosis in Children with Brain Tumors, Using National Medicaid Claims from 2009 to 2012
Michelle Yun, MD |
| 04:30 PM - 04:50 PM | Speaker |
Adaptor Protein Complex 4 Deficiency: A Paradigm of Childhood-onset Hereditary Spastic Paraplegia Associated With Defective Protein Trafficking
Darius Ebrahimi-Fakhari, MD, PhD |
| 04:50 PM - 05:10 PM | Speaker |
A Ball, a Stick, a Stopwatch, and a Sharpened Romberg Can be used for the Assessment and Management of Concussion in Pediatric Patients within 8 weeks of Injury
William D. Brown, MD |
| 05:10 PM - 05:30 PM | Speaker |
Physiologic dysfunction, demyelination, and retinal ganglion cell loss in mice with neurofibromatosis and optic pathway gliomas
Steven F. Stasheff, MD |
| Toni Pearson, MBBS | Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Pearson has received research support from NIH. |
| Francisca Millan Zamora, MD | No disclosure on file |
| Michelle Yun, MD | No disclosure on file |
| Darius Ebrahimi-Fakhari, MD, PhD | Dr. Ebrahimi-Fakhari has received personal compensation in the range of $0-$499 for serving as a Consultant for Alcimed Inc.. The institution of Dr. Ebrahimi-Fakhari has received research support from CureAP4 Foundation, CureSPG50 Foundation, Spastic Paraplegia Foundation, Manton Center for Orphan Disease Research, BPAN Warriors Foundation, NIH/NINDS. Dr. Ebrahimi-Fakhari has received publishing royalties from a publication relating to health care. |
| William D. Brown, MD | No disclosure on file |
| Steven F. Stasheff, MD | No disclosure on file |
| Erika F. Augustine, MD, FAAN | The institution of Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Augustine has received research support from NIH. The institution of Dr. Augustine has received research support from Beyond Batten Disease Foundation. Dr. Augustine has received publishing royalties from a publication relating to health care. Dr. Augustine has a non-compensated relationship as a Member, Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Jonathan W. Mink, MD, PhD, FAAN | The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |